Today the governing Board of the California Institute for Regenerative Medicine (CIRM) expanded efforts related to the $5 million in emergency funding for the CIRM COVID-19 program. The new guidelines mean that inception discovery projects (DISC1), whose goal is developing new and transformational ideas, will now be eligible for CIRM COVID-19 funding. These projects can … Continue reading CIRM Board Expands Efforts of COVID-19 Program
Maria T. Millan
CIRM Board Expands COVID-19 Efforts
Coronavirus particles, illustration. Courtesy KTSDesign/Science Photo Library This past Friday, the governing Board of the California Institute for Regenerative Medicine (CIRM) expanded the eligibility criteria for COVID-19 related projects to develop new treatments against the virus. Just two weeks ago, the Board approved $5 million in emergency funding for COVID-19 research. One major addition is allowing research related … Continue reading CIRM Board Expands COVID-19 Efforts
CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”
CIRM is commending the US Food and Drug Administration (FDA) for its action against two stem cell clinics offering unapproved therapies. On Wednesday, the FDA filed two complaints in federal court seeking a permanent injunction against California Stem Cell Treatment Center Inc. and US Stem Cell Clinic LLC. of Sunrise, Florida. The FDA says the … Continue reading CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”
The Stem Cellar 